XTX Topco’s Meridian Bioscience Inc VIVO Stock Holding History

XTX Topco’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,311	Closed	-$244K	–	1184
2021 Q1	$244K	Buy	+9,311	New	+$221K	0.12%	393

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's VIVO Position: Q2 2021 in Review

XTX Topco sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 9,311 shares — an estimated $244K sold.

XTX Topco first reported a position in VIVO in Q1 2021 and held it in 1 quarter. The position peaked at $244K in Q1 2021. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

XTX Topco reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
XTX Topco sold 9,311 Meridian Bioscience Inc shares in Q2 2021, an estimated $244K.
XTX Topco first reported a position in Meridian Bioscience Inc in Q1 2021 and held it in 1 quarter.
XTX Topco's Meridian Bioscience Inc position peaked at $244K in Q1 2021.
189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on XTX Topco's 13F filing for Q2 2021, filed 12 Aug 2021.